1
|
Suzuki S, Kita Y, Fukunishi I, Kotani K, Yamada I, Johnson K, Honma T, Aranami Y, Ekataksin W, Ohata AY. Living-Related Liver Transplantation: A Thai Family's Stressors and Concerns. Prog Transplant 2016. [DOI: 10.1177/152692480201200107] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
This case study reviews the experience of a Thai family who traveled to Japan for living-related liver transplantation. The recipient experienced multiple problems after transplantation, which placed additional stress on the family. The cultural gap and language barrier resulted in a lack of understanding and often made it difficult for the medical team and family to communicate effectively. However, the use of interpreters helped to resolve these problems. This study shows that it is especially important for transplant coordinators and social workers to facilitate the collaboration and understanding between families and the medical team when cultural and language differences exist.
Collapse
Affiliation(s)
- Shiho Suzuki
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Yoshiaki Kita
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Isao Fukunishi
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Katsuyo Kotani
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Ikan Yamada
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Karin Johnson
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Terumi Honma
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Yoshi Aranami
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Wichai Ekataksin
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| | - Andrew Y. Ohata
- Tokai University, Kanagawa, Japan (SS), Japan Railway Tokyo General Hospital, Tokyo, Japan (YK), Tokyo Institute of Psychiatry, Tokyo Metropolitan Organization for Medical Research (IF), Japan-Thailand Center, Tokyo (KK), Chiang Mai University, Chiang Mai, Thailand (SY), Japan Chapter of Transplant Recipients International Organization, Tokyo (KJ), Kanto Biomedical Laboratory, Saitama, Japan (TH), Tokyo Medical and Dental University (WE), St Timothy's Church, Tokyo (AYO)
| |
Collapse
|
2
|
Coebergh JAF, Lauw RF, Bots R, Sommer IEC, Blom JD. Musical hallucinations: review of treatment effects. Front Psychol 2015; 6:814. [PMID: 26136708 PMCID: PMC4468361 DOI: 10.3389/fpsyg.2015.00814] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Accepted: 05/28/2015] [Indexed: 01/18/2023] Open
Abstract
BACKGROUND Despite an increased scientific interest in musical hallucinations over the past 25 years, treatment protocols are still lacking. This may well be due to the fact that musical hallucinations have multiple causes, and that published cases are relatively rare. OBJECTIVE To review the effects of published treatment methods for musical hallucinations. METHODS A literature search yielded 175 articles discussing a total number of 516 cases, of which 147 articles discussed treatment in 276 individuals. We analyzed the treatment results in relation to the etiological factor considered responsible for the mediation of the musical hallucinations, i.e., idiopathic/hypoacusis, psychiatric disorder, brain lesion, and other pathology, epilepsy or intoxication/pharmacology. RESULTS Musical hallucinations can disappear without intervention. When hallucinations are bearable, patients can be reassured without any other treatment. However, in other patients musical hallucinations are so disturbing that treatment is indicated. Distinct etiological groups appear to respond differently to treatment. In the hypoacusis group, treating the hearing impairment can yield significant improvement and coping strategies (e.g., more acoustic stimulation) are frequently helpful. Pharmacological treatment methods can also be successful, with antidepressants being possibly more helpful than antiepileptics (which are still better than antipsychotics). The limited use of acetylcholinesterase inhibitors has looked promising. Musical hallucinations occurring as part of a psychiatric disorder tend to respond well to psychopharmacological treatments targeting the underlying disorder. Musical hallucinations experienced in the context of brain injuries and epilepsy tend to respond well to antiepileptics, but their natural course is often benign, irrespective of any pharmacological treatment. When intoxication/pharmacology is the main etiological factor, it is important to stop or switch the causative substance or medication. CONCLUSION Treatments for musical hallucinations tend to yield favorable results when they target the main etiological factor of these phenomena. There is a need to establish the natural course of musical hallucinations, their response to non-pharmacological treatments, and their effects on the patient's quality of life. There is also a need to standardize the assessment of treatment responses, and document long-term follow up.
Collapse
Affiliation(s)
- Jan A. F. Coebergh
- Department of Neurology, Haga HospitalThe Hague, Netherlands
- Department of Neurology, Ashford/St. Peter's HospitalChertsey, UK
- Department of Neurology, St. George's HospitalLondon, UK
| | - R. F. Lauw
- Parnassia Psychiatric InstituteThe Hague, Netherlands
| | - R. Bots
- ‘S Heeren LooNoordwijk, Netherlands
| | - I. E. C. Sommer
- Department of Psychiatry, University Medical Center UtrechtUtrecht, Netherlands
- Brain Centre Rudolf MagnusUtrecht, Netherlands
| | - J. D. Blom
- Parnassia Psychiatric InstituteThe Hague, Netherlands
- Department of Psychiatry, University of GroningenGroningen, Netherlands
| |
Collapse
|
4
|
Cope TE, Baguley DM. Is musical hallucination an otological phenomenon? a review of the literature. Clin Otolaryngol 2010; 34:423-30. [PMID: 19793274 DOI: 10.1111/j.1749-4486.2009.02013.x] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND Musical hallucination is the subjective experience of hearing music, or aspects of music, when none is being played, and as such is a disorder of the processing of complex sounds. OBJECTIVE OF REVIEW To determine the extent to which the otological system is responsible for musical hallucination, and to evaluate approaches to clinical management. TYPE OF REVIEW A review of all studies and literature reviews pertaining to musical hallucination, supplemented by inclusion of informative case reports. SEARCH STRATEGY A systematic search of multiple databases carried out on 22nd March 2009 was complemented by referral to the reference lists of included manuscripts. RESULTS Although not always troublesome in itself, musical hallucination can be a marker of underlying pathology in the ear or brain, or indicate obsessive-compulsive traits or social isolation, and is likely to be clinically underreported. Associations have been reported with hearing loss, female gender, social isolation and being over 60 years of age, although it is rare even in this group, and these may well not be independent risk factors. Robust comparative analysis of these factors with controls has yet to be undertaken. Underlying causes include neurovascular pathology, psychiatric disorders and opioid medications, however these are absent in the majority of cases. CONCLUSIONS This review supports the proposal that the otological system plays a role in the pathogenesis of musical hallucination. Hearing impairment may act as an initiating factor, and the primary dysfunction is overactivity of auditory association cortex, although an impairment of higher-level inhibition does also seem necessary. Once underlying sinister causes have been excluded, first line treatment should be explanation of the condition and optimisation of hearing. Medications have a role only in selected patient groups.
Collapse
Affiliation(s)
- T E Cope
- Auditory Research Group, Medical School, Institute of Neuroscience, University of Newcastle-upon-Tyne, UK
| | | |
Collapse
|